BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23163035)

  • 1. [Evaluation of the effect of mass vaccination against hepatitis B in the Russian Federation].
    Klushkina VV; Kozhanova TV; Bazhazhina PG; Popova OE; Il'chenko LIu; Kiuregian KK; Mikhaĭlov MI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):42-8. PubMed ID: 23163035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Leroux-Roels G; Kuriyakose S; Leyssen M; Jacquet JM
    J Viral Hepat; 2011 May; 18(5):369-75. PubMed ID: 20384962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia.
    Klushkina VV; Kyuregyan KK; Kozhanova TV; Popova OE; Dubrovina PG; Isaeva OV; Gordeychuk IV; Mikhailov MI
    PLoS One; 2016; 11(6):e0157161. PubMed ID: 27280884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.
    Bialek SR; Helgenberger L; Fischer GE; Bower WA; Konelios M; Chaine JP; Armstrong G; Williams IT; Bell BP
    Pediatr Infect Dis J; 2010 Jan; 29(1):18-22. PubMed ID: 19841605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y; Chen P; Xia JR; Zhang LP
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
    Zhang L; Liu JY; Lyu JJ; Yan BY; Feng Y; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):475-479. PubMed ID: 28592088
    [No Abstract]   [Full Text] [Related]  

  • 10. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Rodríguez Lay LLA; Bello Corredor M; Montalvo Villalba MC; Chibás Ojeda AG; Sariego Frómeta S; Diaz González M; Abad Lamoth Y; Sánchez Wong M; Sausy A; Muller CP; Hübschen JM
    Arch Virol; 2017 Aug; 162(8):2393-2396. PubMed ID: 28439708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program.
    Harpaz R; McMahon BJ; Margolis HS; Shapiro CN; Havron D; Carpenter G; Bulkow LR; Wainwright RB
    J Infect Dis; 2000 Feb; 181(2):413-8. PubMed ID: 10669320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
    Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seropositivity for hepatitis B virus, vaccination coverage, and vaccine response in dentists from Campo Grande, Mato Grosso do Sul, Brazil.
    Batista SM; Andreasi MS; Borges AM; Lindenberg AS; Silva AL; Fernandes TD; Pereira EF; Basmage EA; Cardoso DD
    Mem Inst Oswaldo Cruz; 2006 May; 101(3):263-7. PubMed ID: 16862319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
    Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
    Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination.
    Asadi Mobarkhan FA; Manuylov VA; Karlsen AA; Kichatova VS; Potemkin IA; Lopatukhina MA; Isaeva OV; Mullin EV; Mazunina EP; Bykonia EN; Kleymenov DA; Popova LI; Gushchin VA; Tkachuk AP; Saryglar AA; Kravchenko IE; Sleptsova SS; Romanenko VV; Kuznetsova AV; Solonin SA; Semenenko TA; Mikhailov MI; Kyuregyan KK
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women.
    Lu LL; Chen BX; Wang J; Wang D; Ji Y; Yi HG; Chen T; Zhang Y; Petersen E; Li Q; Qu C
    Int J Infect Dis; 2014 Nov; 28():41-4. PubMed ID: 25245000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.